Latest News about ABT
Recent news which mentions ABT
Friday Retreat: After Wild Thursday Rally, Market Stumbles into Weekend as Inflation Fears Grow
October 17, 2022
From Benzinga
3 Dividend Stocks to Buy Now for a Lifetime of Passive Income
October 17, 2022
From Motley Fool
From Motley Fool
3 Beaten-Down Stocks to Buy and Hold
October 15, 2022
From Motley Fool
Why the Bear Market May Not Be Over Anytime Soon
October 13, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
October 12, 2022
From Benzinga
Better Bear-Market Buy: Abbott Laboratories vs. AbbVie Stock
October 11, 2022
From Motley Fool
3 Diabetes Care Stocks That Could Help Set You Up for Life
October 09, 2022
From Motley Fool
2 Top Healthcare Stocks to Buy Right Now
October 08, 2022
From Motley Fool
3 Great Dividend Stocks to Buy in October
October 08, 2022
From Motley Fool
Why DexCom Stock Popped on Friday, Even as the Market Crumbled
October 07, 2022
From Motley Fool
Best Stocks 2022: What’s Not to Like About AbbVie (ABBV) Stock?
October 05, 2022
From InvestorPlace
3 Dividend Stocks to Buy In October and Hold Forever
October 05, 2022
From Motley Fool
Here's Why This Dividend King Is a Buy
October 01, 2022
From Motley Fool
Want to Get Richer? 3 Top Stocks to Buy Now and Hold Forever
September 28, 2022
From Motley Fool
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
From Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
September 27, 2022
From InvestorPlace
Got $2,000? Invest In These 2 Perpetually Growing Stocks
September 26, 2022
From Motley Fool
2 Growth Stocks Down 14% to 28% to Buy and Hold Forever
September 26, 2022
From Motley Fool
Awakn And Catalent's Partnership Could Provide Hope For People Suffering From Addiction
September 26, 2022
From Benzinga
Is AbbVie a Buy?
September 24, 2022
From Motley Fool
‘If the FDA is expected to do more, it needs more’: FDA investigation into baby-formula crisis points to its own shortcomings. But shortages persist.
September 23, 2022
From MarketWatch
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
